Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-10-30FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA supplemental approval for a generic product of Carbidopa and Levodopa by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2009-10-29FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for a generic Carbidopa and Levodopa product.
-
CLINICAL_TRIALS trial_result · 2009-10-20Clinical Trial Update: Repetitive Transcranial Stimulation (r-TMS) Treatment for Patients With Parkinson's Disease [Phase 2]
This document reports a completed Phase 2 clinical trial evaluating repetitive transcranial stimulation (r-TMS) in patients with Parkinson's…
-
CLINICAL_TRIALS trial_result · 2009-10-16Clinical Trial Update: The Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) Treatment on Motor and Cognitive Measurements in Patients With Parkinson's Disease [NA]
Clinical trial update on the effects of low-frequency repetitive transcranial magnetic stimulation on motor and cognitive outcomes in Parkin…
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Treadmill and Music Cueing for Gait Training in Mild to Moderate Parkinson's Disease [NA]
This clinical trial update reports the completion of a study evaluating treadmill and music cueing as gait training for individuals with Par…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-09-28FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original Abbreviated New Drug Application for Carbidopa and Levodopa, a generic treatment for Parkinson's disease, developed…
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms [Phase 4]
A Phase 4 trial comparing pramipexole to placebo in Parkinson's disease patients with depressive symptoms reported results. The study result…
-
FDA approval · 2009-08-31FDA Approved: BENZTROPINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s benztropine mesylate as an original ANDA application (generic).
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease [Phase 2]
A Phase 2 trial evaluating Aplindore for efficacy and safety in early Parkinson disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease [NA]
A completed clinical trial studying the effects of dopaminergic medications on dopamine transporter density in people with Parkinson disease…
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Treadmill Training With Additional Body Load: Effects on Gait of Subjects With Parkinson´s Disease [NA]
A completed clinical trial evaluated treadmill training with added body load to assess its effects on gait in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Safety and Tolerability Study of Cogane™ in Healthy Volunteers and Parkinson's Disease Patients [Phase 1]
Phase 1 safety and tolerability study of Cogane™ in healthy volunteers and Parkinson's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients [Phase 2]
Phase 2 study evaluating MYOBLOC for treating sialorrhea in Parkinson's disease has completed, with results posted August 13, 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of levetiracetam versus placebo for levodopa-induced dyskinesias in advanced Parkinson's d…
-
FDA approval · 2009-07-31FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' generic carbidopa/levodopa in an original ANDA submission, expanding access to this Parkinso…
-
FDA approval · 2009-07-28FDA Approved: BENZTROPINE MESYLATE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for benztropine mesylate (generic) by Fresenius Kabi USA, LLC, expanding access to treatment for Parki…
-
CLINICAL_TRIALS research · 2009-07-22Clinical Trial Update: Deep Brain Stimulation (DBS) For Parkinson's Disease: Caudal Zona Incerta Versus Subthalamic Nucleus [NA]
A clinical trial is comparing deep brain stimulation targets Caudal Zona Incerta and Subthalamic Nucleus for Parkinson's disease; the trial …
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease [Phase 2]
This completed Phase 2 dose-finding safety study evaluated BIIB014 in combination with levodopa in patients with moderate to late-stage Park…
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery [Phase 4]
Phase 4 trial update evaluating the rotigotine transdermal patch (Neupro) in Parkinson's disease patients undergoing surgery; results were p…
-
CLINICAL_TRIALS research · 2009-07-02Clinical Trial Update: Twins and the Risk of Parkinson's Disease: A Clinical and Imaging Study
A clinical and imaging study update examining whether twin status affects the risk of developing Parkinson's disease.
-
FDA approval · 2009-06-30FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for TASMAR (tolcapone) submitted by Bausch Health US LLC.
-
FDA approval · 2009-06-05FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith Laboratories' supplemental application for amantadine hydrochloride (generic product). This action confirms approv…
-
FDA approval · 2009-06-04FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for amantadine hydrochloride from Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease [Phase 2]
Phase 2 trial evaluating fipamezole for motor dysfunction in Parkinson's disease has completed, reporting on safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine [Phase 3]
Phase 3 trial evaluating safety and tolerability of switching Parkinson's patients from ropinirole to rotigotine; results were posted in 200…